Trial intelligence / Profile preview

Topical Tranexamic Acid in Total Knee Arthroplasty

NCT00985920Phase 4Completed

Sponsor
University Health Network
Start
Sep 2007
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tranexamic acid (3 arms), sponsored by University Health Network. Primary endpoint: Calculated blood loss. Started Sep 2007; status: completed.

02

Drugs

tranexamic acid

Beyond the preview

Go deeper on NCT00985920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00985920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call